Key Metrics of InflaRx N.V.
Revenue—FY 2020
Operating income—
Net profit−€34.0M▲ 0.0% YoY
Shareholders' equity€77.9M
Market cap$225MIFRX · $1.53
Competitors10identified
About InflaRx N.V.
Sectors
Company details
- Founded
- 2017
- Listed
- Nasdaq: IFRX (since 2017)
Operational Areas of InflaRx N.V.
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameInflaRx N.V.
TickerIFRX
ExchangeNasdaq
CountryGermany
SEC CIK0001708688
Listed since2017
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Website—
US market & SEC filings
IFRX · Nasdaq · SEC CIK 0001708688
Last price · 25 Oct 2026
$1.53
−1.29%
Market cap$225M
P/E—On FY 2020 diluted EPS
Volume404,208
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOGermanyListed 2017
IFRX share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of InflaRx N.V.
Competitors10identified
Countries1most in Germany
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | the-odin.com | — | Solan, Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | morphosys.com | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | curevac.com | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | medigene.com | — | Jaipur, Germany | |
 Evotec |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | evotec.com | 1993 | Germany |
| Part of GSK. | glaxosmithkline.de | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | miltenyibiotec.com | — | Hyderabad, Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | mwg-biotech.com | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | promega.com | — | Mumbai, Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | gatc-biotech.com | — | Germany |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.